3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas

被引：0

作者：

Tabouret, Emeline

Furtner, Julia

Graillon, Thomas

Silvani, Antonio

Le Rhun, Emilie

Soffietti, Riccardo

Lombardi, Giuseppe

Sepulveda, Juan Manuel

Brandal, Petter

Brazil, Lucy

Bendszus, Martin

Golfinopoulos, Vassilis

Gorlia, Thierry

Weller, Michael

Sahm, Felix

Wick, Wolfgang

Preusser, Matthias

机构：

[1] Aix Marseille Univ, CNRS, Inst Neurophysiopathol, Serv Neurooncol,INP,CHU Timone,APHM, Marseille, France

[2] Med Univ Vienna, Biomed Imaging & Image Guided Therapy, Vienna, Austria

[3] CHU Timone, Neurosurg Dept, Marseille, France

[4] Neurol Inst Carlo Besta, Dept Neurooncol, Milan, Italy

[5] Univ Zurich Hosp, Zurich, Switzerland

[6] Univ & City Hlth & Sci Hosp, Turin, TO, Italy

[7] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Oncol 1, Padua, Italy

[8] Hosp Univ 12 Octubre, Madrid, Spain

[9] Oslo Univ Hosp, Dept Oncol, Oslo, Norway

[10] Guys Hosp, Ctr Canc, London, England

[11] UKHD, Natl Ctr Tumor Dis NCT, Heidelberg, Germany

[12] German Canc Res Ctr, Heidelberg, Germany

[13] EORTC European Org Res & Treatment Canc, Woluwe St Lambert, Belgium

[14] EORTC, Brussels, Belgium

[15] Univ Hosp, Dept Neurol, Zurich, Switzerland

[16] Univ Zurich, Zurich, Switzerland

[17] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany

[18] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, German Consortium Translat Canc Res DKTK, Heidelberg, Germany

[19] Heidelberg Univ, Heidelberg, Germany

[20] Med Univ Vienna, Div Oncol, Dept Med 1, Vienna, Austria

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2075

引用

页数：1

共 50 条

[1] 3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Tabouret, Emeline
Furtner, Julia
Graillon, Thomas
Silvani, Antonio
Le Rhun, Emilie
Soffietti, Riccardo
Lombardi, Giuseppe
Sepulveda-Sanchez, Juan Manuel
Brandal, Petter
Bendszus, Martin
Golfinopoulos, Vassilis
Gorlia, Thierry
Weller, Michael
Sahm, Felix
Wick, Wolfgang
Preusser, Matthias
NEURO-ONCOLOGY, 2024, 26 (07) : 1302 - 1309
[2] Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Preusser, Matthias
Silvani, Antonio
Le Rhun, Emilie
Soffietti, Riccardo
Lombardi, Giuseppe
Sepulveda, Juan Manuel
Brandal, Petter
Brazil, Lucy
Bonneville-Levard, Alice
Lorgis, Veronique
Vauleon, Elodie
Bromberg, Jacoline
Erridge, Sara
Cameron, Alison
Lefranc, Florence
Clement, Paul M.
Dumont, Sarah
Sanson, Marc
Bronnimann, Charlotte
Balana, Carmen
Thon, Niklas
Lewis, Joanne
Mair, Maximilian J.
Sievers, Philipp
Furtner, Julia
Pichler, Josef
Bruna, Jordi
Ducray, Francois
Reijneveld, Jaap C.
Mawrin, Christian
Bendszus, Martin
Marosi, Christine
Golfinopoulos, Vassilis
Coens, Corneel
Gorlia, Thierry
Weller, Michael
Sahm, Felix
Wick, Wolfgang
NEURO-ONCOLOGY, 2022, 24 (05) : 755 - 767
[3] Salvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas: A Multicenter Study (STORM)
Gallitto, Matthew
Sedor, Geoffrey
Lee, Albert
Pasetsky, Jared
Kinslow, Connor J.
de los Santos, Genesis
Obiri-Yeboah, Derrick
Kshettry, Varun R.
Helis, Corbin A.
Chan, Michael D.
Beckham, Thomas H.
McGovern, Susan L.
Matsui, Jennifer
Palmer, Joshua D.
Bell, Jonathan B.
Mellon, Eric A.
Lakomy, David
Huang, Jiayi
Boor, Ian
Rusthoven, Chad G.
Sisti, Michael B.
Wang, Tony J. C.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (03): : 730 - 737
[4] Trabectedin for recurrent WHO grade 2 or 3 meningiomas-Paving the road for new opportunities
Alvarez-Breckenridge, Christopher A.
Cahill, Daniel P.
Brastianos, Priscilla K.
NEURO-ONCOLOGY, 2022, 24 (05) : 768 - 769
[5] Multi -Institutional Study of Stereotactic Radiosurgery for Recurrent WHO Grade 2/3 Meningiomas: An Interim Analysis
Sedor, G. J.
Lee, A. W.
Gallitto, M.
Pasetsky, J.
Helis, C. A.
Chan, M. D.
Beckham, T.
McGovern, S. L.
Wang, T. J. C.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E148 - E148
[6] Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study
Graillon, Thomas
Ferrer, Loic
Siffre, Jason
Sanson, Marc
Peyre, Matthieu
Peyriere, Hadrien
Mougel, Gregory
Autran, Didier
Tabouret, Emeline
Figarella-Branger, Dominique
Barlier, Anne
Kalamarides, Michel
Dufour, Henry
Colin, Thierry
Chinot, Olivier
NEURO-ONCOLOGY, 2021, 23 (07) : 1139 - 1147
[7] 3D Volumetric Measurement of Neurofibromatosis Type 2-Associated Meningiomas: Association Between Tumor Location and Growth Rate
Evers, Stefanie
Verbaan, Dagmar
Sanchez, Esther
Peerdeman, Saskia
WORLD NEUROSURGERY, 2015, 84 (04) : 1062 - 1069
[8] The agreement between 3D, standard 2D and triplane 2D speckle tracking: Effects of image quality and 3D volume rate
Trache T.
Stöbe S.
Tarr A.
Pfeiffer D.
Hagendorff A.
Echo Research & Practice, 2014, 1 (2): : 71 - 83
[9] 2D/3D registration of freehand SPECT and planar scintigraphy for clinical evaluation of 3D thyroid scintigraphy
Wendler, T.
Feng, X.
Herrmann, K.
Lasser, T.
Traub, J.
Ziegler, S. I.
Navab, N.
Buck, A. K.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S281 - S281
[10] 2D/3D registration of freehand SPECT and planar scintigraphy for clinical evaluation of 3D thyroid scintigraphy
Feng, X.
Szajkowska, K.
Lasser, T.
Ziegler, S. I.
Navab, N.
Wendler, T.
WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT 2 - DIAGNOSTIC IMAGING, 2009, 25 : 737 - 740

← 1 2 3 4 5 →